Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes:: Role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme

被引:85
作者
Wold, LE
Ceylan-Isik, AF
Fang, CX
Yang, XP
Li, SY
Sreejayan, N
Privratsky, JR
Ren, J [1 ]
机构
[1] Univ Wyoming, Div Pharmaceut Sci, Laramie, WY 82071 USA
[2] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA
[3] Univ N Dakota, Sch Med, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA
关键词
antioxidant; diabetes; myocyte; contraction; Ca2+ cycling protein; PARP; MHC; free radical;
D O I
10.1016/j.freeradbiomed.2005.12.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic cardiomyopathy contributes to high morbidity and mortality in diabetic populations. It is manifested by compromised ventricular contraction and prolonged relaxation attributable to multiple causative factors including oxidative stress. This study was designed to examine the effect of cardiac overexpression of the heavy metal scavenger metallothionein (MT) on cardiac contractile function, intracellular Ca2+ cycling proteins, stress-activated signaling molecules and the myosin heavy chain (MHC) isozyme in diabetes. Adult male wild-type (FVB) and MT transgenic mice were made diabetic by a single injection of streptozotocin (STZ). Contractile properties were evaluated in cardiomyocytes including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR90), maximal velocity of shortening/relengthening (+/- dL/dt) and intracellular Ca2+ fluorescence. Diabetes significantly depressed PS, +/- dL/dt, prolonged TPS, TR90 and intracellular Ca2+ clearing, elevated resting intracellular Ca2+, reduced caffeine-induced sarcoplasmic reticulum Ca2+ release and dampened stress tolerance at high stimulus frequencies. NIT itself exhibited little effect on myocyte mechanics but it significantly alleviated STZ-induced myocyte contractile dysfunctions. Diabetes enhanced expression of the AT(1) receptor, phospholamban, the p47(phox) NADPH oxidase Subunit and poly(ADP-ribose) polymerase (PARP), depressed the level of SERCA2a, Na+-Ca2+ exchanger and triggered a beta-MHC isozyme switch. All of these STZ-induced alterations with the exception of depressed SERCA2a and enhanced phospholamban were reconciled by MT. Collectively, these data suggest a beneficial effect of MT in the therapeutics of diabetic cardiomyopathy, possibly through a mechanism related to NADPH oxidase, PARP and MHC isozyme switch. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1419 / 1429
页数:11
相关论文
共 33 条
[21]   Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse [J].
Ren, J ;
Porter, JE ;
Wold, LE ;
Aberle, NS ;
Muralikrishnan, D ;
Haselton, JR .
NEUROBIOLOGY OF AGING, 2004, 25 (01) :131-138
[22]   Increases in insulin-like growth factor-1 level and peroxidative damage after gestational ethanol exposure in rats [J].
Ren, J ;
Roughead, ZK ;
Wold, LE ;
Norby, FL ;
Rakoczy, S ;
Mabey, RL ;
Brown-Borg, HM .
PHARMACOLOGICAL RESEARCH, 2003, 47 (04) :341-347
[23]   Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes [J].
Ren, J ;
Davidoff, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (01) :H148-H158
[24]   Role of oxygen derived radicals for vascular dysfunction in the diabetic heart:: Prevention by α-tocopherol? [J].
Rösen, P ;
Du, XL ;
Tschöpe, D .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) :103-111
[25]   Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression [J].
Rundell, VLM ;
Geenen, DL ;
Buttrick, PM ;
de Tombe, PP .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (01) :H408-H413
[26]   Mechanisms underlying depressed Na+/Ca2+ exchanger activity in the diabetic heart [J].
Schaffer, SW ;
BallardCroft, C ;
Boerth, S ;
Allo, SN .
CARDIOVASCULAR RESEARCH, 1997, 34 (01) :129-136
[27]  
Shen X, 2005, METH MOLEC MED, V112, P379
[28]   Cardioprotective effects of poly (ADP-ribose) polymerase inhibition [J].
Szabó, C .
PHARMACOLOGICAL RESEARCH, 2005, 52 (01) :34-43
[29]  
Ungvari Zoltan, 2005, Current Vascular Pharmacology, V3, P221, DOI 10.2174/1570161054368607
[30]   Oxidative stress and stress signaling: menace of diabetic cardiomyopathy [J].
Wold, LE ;
Ceylan-Isik, AF ;
Ren, J .
ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) :908-917